Concepedia

Publication | Closed Access

Serum Markers in Patients with Resectable Pancreatic Adenocarcinoma: Macrophage Inhibitory Cytokine 1 versus CA19-9

DOI

215

Citations

40

References

2006

Year

Jens Koopmann, C. Nicole Rosenzweig, Zhen Zhang, Marcia Irene Canto, David A. Brown, Mark Hunter, Charles J. Yeo, Daniel W. Chan, Samuel N. Breit, Michael Goggins
Clinical Cancer Research

Abstract

In the differentiation of patients with resectable pancreatic cancer from controls, serum MIC-1 outperforms other markers including CA19-9.

References

YearCitations

Page 1